United States · FDA National Drug Code directory

Losartan potassium Tablets, 50 mg

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-1817_fb077532-f94e-44e1-afd3-6be55c4062c8
Product NDC
71335-1817
Form
TABLET
Composition / generic term
losartan potassium
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20120918
Source listing expiry
20261231

Source-listed ingredients

  • LOSARTAN POTASSIUM — 50 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE (71335-1817-1) · 71335-1817-1
  • 90 TABLET in 1 BOTTLE (71335-1817-2) · 71335-1817-2
  • 60 TABLET in 1 BOTTLE (71335-1817-3) · 71335-1817-3
  • 120 TABLET in 1 BOTTLE (71335-1817-4) · 71335-1817-4
  • 100 TABLET in 1 BOTTLE (71335-1817-5) · 71335-1817-5
  • 180 TABLET in 1 BOTTLE (71335-1817-6) · 71335-1817-6
  • 10 TABLET in 1 BOTTLE (71335-1817-7) · 71335-1817-7
  • 7 TABLET in 1 BOTTLE (71335-1817-8) · 71335-1817-8

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →